Publication Year

Lau C, JL Butenhoff, JM Rogers. 2004. The developmental toxicity of perfluoroalkyl acids and their derivatives. Toxicol Appl Pharmacol 198(2):231-241; doi: 10.1016/j.taap.2003.11.031.

Grasty RC, Roberts N, Grey BE, Lau C, Rogers JM. 2004. Perfluorooctane sulfonate (PFOS) alters lung development in the neonatal rat. Birth Defects Res A 70(5)264, Abstract 42; doi: 10.1002/bdra.20026.

Degitz SJ, Rogers JM, Zucker RM, Hunter ES III. 2004. Developmental toxicity of methanol: Pathogenesis in CD-1 and C57BL/6J mice exposed in whole embryo culture. Birth Defects Res A 70(4):179–184; doi: 10.1002/bdra.20009. PMID: 15108244.

Urban JD, Gay EA, Mailman RB. Decreased neurological side-effects with aripiprazole: A result of functional selectivity of the D2 receptor? Society of Toxicology 43rd Annual Meeting, Baltimore, MD, March 2004.

Staskal DF, Diliberto JJ, DeVito MJ, Birnbaum LS. Disposition of 2,2’,4,4’-tetrabromodiphenylether (BDE 47) in female mice. Society for Toxicology 43rd Annual Meeting, Baltimore, MD, March 2004.

Grasty RC, Roberts N, Grey BE, Lau C, Rogers JM. Effects of prenatal exposure to perfluorooctane sulfonate on the developing lung in the rat. Society for Toxicology 43rd Annual Meeting, Baltimore, MD, March 2004.

Thompson CM, Wojno H, Greiner E, May EL, Rice KC, Selley DE. 2004. Activation of G-proteins by morphine and codeine congeners: Insights to the relevance of O- and N-demethylated metabolites at μ- and δ-opioid receptors. J Pharmacol Exper Therapeut 308(2):547–554; doi: 10.1124/jpet.103.058602. PMID: 14600248.

Birnbaum LS, Staskal DF. 2004. Brominated flame retardants: Cause for concern? Environ Health Perspect 112(1):9-17; doi: 10.1289/ehp.6559.